MLchartDataset catalogue

Carmustine with propylene glycol formulation VI-0609

Term · Oncology and biomedicine · MLC-T-ONC-012313

An injectable ethanol-free formulation containing carmustine with propylene glycol, with antineoplastic activity. Upon administration, carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. The ethanol-free formulation of carmustine may lead to fewer toxicities than the ethanol-based formulation.

Table 1. Record
IdentifierMLC-T-ONC-012313
FieldOncology and biomedicine
Synonymscarmustine ethanol-free formulation VI-0609; carmustine formulation VI-0609
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012313",
  "term": "Carmustine with propylene glycol formulation VI-0609",
  "field": "Oncology and biomedicine",
  "definition": "An injectable ethanol-free formulation containing carmustine with propylene glycol, with antineoplastic activity. Upon administration, carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. The ethanol-free formulation of carmustine may lead to fewer toxicities than the ethanol-based formulation.",
  "synonyms": [
    "carmustine ethanol-free formulation VI-0609",
    "carmustine formulation VI-0609"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/carmustine-with-propylene-glycol-formulation-vi-0609/"
}

Record 4,263 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.